Congenital Heart Disease

Adults with congenital heart disease demonstrated poorer neurocognitive function compared with those without it, according to research published in the Journal of the American Heart Association.

Supplementation with eicosapentaenoic acid and docosahexaenoic acid may reduce the risk for some CVD outcomes, including fatal MI and CHD events, researchers found.

Prevention of CHD may not only prolong life-years, but it may also improve productivity, leading to improvement in gross domestic product, researchers reported.

Adults with ventricular septal defects had poorer exercise capacity compared with adults without them, researchers found.

From 2008 to 2017, overall rates of recurrent MI declined among men and women in the U.S. in the 365 days after discharge, according to research published in Circulation.

The European Society of Cardiology released a new guideline on adult congenital heart disease emphasizing lifelong follow-up and endorsing catheter-based interventions when possible.

Certain antidepressants appeared associated with specific birth defects, according to study results published in JAMA Psychiatry.

Among adults with congenital heart disease hospitalized for HF, mortality risk remained high for up to 4 years after hospital discharge, according to a study published in Circulation: Heart Failure.

There appears to be no increase in surgeries for congenital heart disease as a result of the 2011 Fukushima Daiichi nuclear accident, researchers reported.

Women with congenital heart defects were more likely to experience cardiac and obstetric complications during pregnancy compared with women without heart defects, researchers reported.